Conservest Capital Advisors Inc. Purchases 912 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Conservest Capital Advisors Inc. grew its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.4% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 38,991 shares of the exchange traded fund’s stock after acquiring an additional 912 shares during the period. SPDR S&P Biotech ETF accounts for approximately 0.4% of Conservest Capital Advisors Inc.’s investment portfolio, making the stock its 29th biggest position. Conservest Capital Advisors Inc. owned 0.05% of SPDR S&P Biotech ETF worth $3,482,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the company. James J. Burns & Company LLC lifted its stake in shares of SPDR S&P Biotech ETF by 5.0% in the 3rd quarter. James J. Burns & Company LLC now owns 3,062 shares of the exchange traded fund’s stock valued at $224,000 after acquiring an additional 146 shares during the last quarter. Greenwich Wealth Management LLC lifted its stake in shares of SPDR S&P Biotech ETF by 1.4% in the 4th quarter. Greenwich Wealth Management LLC now owns 11,451 shares of the exchange traded fund’s stock valued at $1,022,000 after acquiring an additional 155 shares during the last quarter. Moser Wealth Advisors LLC lifted its stake in shares of SPDR S&P Biotech ETF by 10.4% in the 3rd quarter. Moser Wealth Advisors LLC now owns 2,041 shares of the exchange traded fund’s stock valued at $149,000 after acquiring an additional 193 shares during the last quarter. Viewpoint Capital Management LLC raised its position in SPDR S&P Biotech ETF by 25.0% during the 3rd quarter. Viewpoint Capital Management LLC now owns 1,000 shares of the exchange traded fund’s stock worth $73,000 after purchasing an additional 200 shares during the last quarter. Finally, HB Wealth Management LLC raised its position in SPDR S&P Biotech ETF by 4.9% during the 4th quarter. HB Wealth Management LLC now owns 4,280 shares of the exchange traded fund’s stock worth $382,000 after purchasing an additional 200 shares during the last quarter.

SPDR S&P Biotech ETF Trading Up 1.5 %

NYSEARCA:XBI traded up $1.27 during trading hours on Friday, hitting $83.49. 10,452,779 shares of the company were exchanged, compared to its average volume of 11,723,970. The stock has a market capitalization of $6.49 billion, a price-to-earnings ratio of 11.47 and a beta of 1.08. SPDR S&P Biotech ETF has a one year low of $63.80 and a one year high of $103.52. The company has a fifty day simple moving average of $92.69 and a 200 day simple moving average of $84.72.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.